CFM
BSX icon

Cornerstone Financial Management’s Boston Scientific BSX Stock Holding History

Cornerstone Financial Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
280
+100
+56% +$5.43K 0.01% 417
2026
Q1 		$11.3K Sell
180
-20
-10% -$1.6K 0.01% 287
2025
Q4 		$19.1K Buy
+200
New +$19.6K 0.02% 195

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cornerstone Financial Management's BSX Position: Q2 2026 in Review

Cornerstone Financial Management increased its Boston Scientific (BSX) stake by 56% in Q2 2026, buying an estimated $5.43K and bringing the position to 280 shares worth $11.9K. The position accounts for 0.01% of the portfolio, ranked #417.

Cornerstone Financial Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.1K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cornerstone Financial Management held 280 shares of Boston Scientific worth $11.9K as of Q2 2026.
  • Cornerstone Financial Management bought 100 Boston Scientific shares in Q2 2026, an estimated $5.43K.
  • Boston Scientific made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #417 holding.
  • Cornerstone Financial Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's Boston Scientific position peaked at $19.1K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.